Medibio (ASX: MEB) (OTC: MDBIF) CEO Interview with David Kaysen. Mr. Kaysen recently came on board as the new CEO, in this interview he discusses Medibio’s mental health monitoring technologies, ongoing progress towards full-scale commercializing, and his background in running small-cap med-tech companies. Kaysen sees 2019 as a “very important year for Medibio” with commercialization rollout, capital raising and FDA regulatory approvals.
Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of […]
Pulmatrix (NASDAQ: PULM) Investor Presentation 9/5/2018 Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super […]
Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
